PDE4B
3',5'-cyclic-AMP phosphodiesterase 4B
Also known as: DPDE4, PDE4B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q07343
- Gene
- PDE4B
- Ensembl
- ENSG00000184588
- Chromosome
- 1
- Canonical length
- 736 aa
- Protein class
- Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Golgi apparatus,Primary cilium,Cytosol
OverviewNCBI Gene
This gene is a member of the type IV, cyclic AMP (cAMP)-specific, cyclic nucleotide phosphodiesterase (PDE) family. The encoded protein regulates the cellular concentrations of cyclic nucleotides and thereby play a role in signal transduction. Altered activity of this protein has been associated with schizophrenia and bipolar affective disorder. Alternative splicing and the use of alternative promoters results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2014]
Canonical amino-acid sequenceUniProt
736 residues, UniProt reviewed canonical sequence.
>Q07343|PDE4B
1 MKKSRSVMTV MADDNVKDYF ECSLSKSYSS SSNTLGIDLW RGRRCCSGNL QLPPLSQRQS
61 ERARTPEGDG ISRPTTLPLT TLPSIAITTV SQECFDVENG PSPGRSPLDP QASSSAGLVL
121 HATFPGHSQR RESFLYRSDS DYDLSPKAMS RNSSLPSEQH GDDLIVTPFA QVLASLRSVR
181 NNFTILTNLH GTSNKRSPAA SQPPVSRVNP QEESYQKLAM ETLEELDWCL DQLETIQTYR
241 SVSEMASNKF KRMLNRELTH LSEMSRSGNQ VSEYISNTFL DKQNDVEIPS PTQKDREKKK
301 KQQLMTQISG VKKLMHSSSL NNTSISRFGV NTENEDHLAK ELEDLNKWGL NIFNVAGYSH
361 NRPLTCIMYA IFQERDLLKT FRISSDTFIT YMMTLEDHYH SDVAYHNSLH AADVAQSTHV
421 LLSTPALDAV FTDLEILAAI FAAAIHDVDH PGVSNQFLIN TNSELALMYN DESVLENHHL
481 AVGFKLLQEE HCDIFMNLTK KQRQTLRKMV IDMVLATDMS KHMSLLADLK TMVETKKVTS
541 SGVLLLDNYT DRIQVLRNMV HCADLSNPTK SLELYRQWTD RIMEEFFQQG DKERERGMEI
601 SPMCDKHTAS VEKSQVGFID YIVHPLWETW ADLVQPDAQD ILDTLEDNRN WYQSMIPQSP
661 SPPLDEQNRD CQGLMEKFQF ELTLDEEDSE GPEKEGEGHS YFSSTKTLCV IDPENRDSLG
721 ETDIDIATED KSPVDTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PDE4B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 71 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 71 nTPM
- skeletal muscle: 42 nTPM
- spinal cord: 38 nTPM
- appendix: 37 nTPM
- cerebral cortex: 37 nTPM
- midbrain: 30 nTPM
Single-cell type
- oligodendrocytes: 4,840 nCPM
- neutrophils: 3,699 nCPM
- oligodendrocyte progenitor cells: 2,473 nCPM
- retinal horizontal cells: 1,765 nCPM
- retinal bipolar cells: 1,183 nCPM
- bergmann glia: 1,175 nCPM
Immune cell
- neutrophil: 90 nTPM
- naive B-cell: 38 nTPM
- memory B-cell: 37 nTPM
- T-reg: 35 nTPM
- eosinophil: 22 nTPM
- naive CD4 T-cell: 21 nTPM
Brain region
- white matter: 237 nTPM
- medulla oblongata: 203 nTPM
- basal ganglia: 188 nTPM
- pons: 182 nTPM
- midbrain: 175 nTPM
- hypothalamus: 164 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.4
- gnomAD pLI
- 0.47
- gnomAD missense Z
- 2.77
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cAMP catabolic process
- cellular response to epinephrine stimulus
- cellular response to lipopolysaccharide
- cellular response to xenobiotic stimulus
- leukocyte migration
- negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway
- negative regulation of cAMP/PKA signal transduction
- negative regulation of relaxation of cardiac muscle
- neutrophil chemotaxis
- neutrophil homeostasis
- positive regulation of interleukin-2 production
- positive regulation of type II interferon production
- regulation of calcium ion transmembrane transport via high voltage-gated calcium channel
- regulation of cardiac muscle cell contraction
- T cell receptor signaling pathway
Molecular functions
- 3',5'-cyclic-AMP phosphodiesterase activity
- 3',5'-cyclic-GMP phosphodiesterase activity
- calcium channel regulator activity
- cAMP binding
- gamma-tubulin binding
- metal ion binding
- transmembrane transporter binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain
- HD/PDEase domain
- 3'5'-cyclic nucleotide phosphodiesterase
- 3'5'-cyclic nucleotide phosphodiesterase, conserved site
- 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain superfamily
- Phosphodiesterase 4 upstream conserved regions (UCR)
- 3'5'-cyclic nucleotide phosphodiesterase
- Phosphodiesterase 4 upstream conserved regions (UCR)
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PDE4B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PDE4B as an antibody target. Whether an autoantibody or antibody against PDE4B could matter depends on whether native PDE4B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PDE4B is annotated at the cell surface, where native PDE4B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PDE4B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...